In the “Other tumors group” four rearrangements involving BRAF gene were detected (three melanoma: BRAF::CNNM2, BRAF::ERC1, BRAF::MAD1L1 and one pancreatic adenocarcinoma BRAF::SND1), but also one ETV6::NTRK3 (colorectal cancer) and one FGFR3::TACC3 (urothelial cancer). This evidence concerns the gene ERC1 and pancreatic adenocarcinoma.